Table II.
Variable | Group | Pretest | Posttest | Within-group P | Between-group P |
---|---|---|---|---|---|
sICAM-1 (pg/ml) | ET | 323.00 ± 91.53 | 334.00 ± 110.84 | 0.501 | 0.472 |
RT | 342.75 ± 88.33 | 333.67 ± 77.24 | 0.499 | ||
Control | 316.67 ± 72.69 | 32.75 ± 73.29 | 0.556 | ||
IL-6 (pg/ml) | ET | 1.88 ± 0.36 | 1.79 ± 0.20 | 0.358 | 0.835 |
RT | 2.02 ± 0.40 | 2.01 ± 0.37 | 0.900 | ||
Control | 1.79 ± 0.26 | 1.98 ± 0.32 | 0.858 | ||
hs-CRP (mg/dl) | ET | 9.33 ± 4.32 | 7.33 ± 2.53 | 0.169 | 0.370 |
RT | 8.50 ± 3.73 | 8.33 ± 4.38 | 0.778 | ||
Control | 7.75 ± 3.72 | 7.75 ± 2.60 | 1.000 | ||
TC (mg/dl) | ET | 188.75 ± 51.32 | 181.50 ± 41.28 | 0.834 | 0.115 |
RT | 199.42 ± 70.93 | 175.08 ± 58.68 | 0.009* | ||
Control | 162.40 ± 30.77 | 158.20 ± 24.25 | 0.022* | ||
TG (mg/dl) | ET | 130.00 ± 13.81 | 123.00 ± 40.98 | 0.834 | 0.977 |
RT | 140.08 ± 106.31 | 120.75 ± 67.98 | 0.433 | ||
Control | 113.58 ± 56.02 | 93.42 ± 30.28 | 0.063 | ||
LDL-C (mg/dl) | ET | 88.83 ± 24.86 | 88.92 ± 16.65 | 0.623 | 0.038** |
RT | 69.00 ± 16.68 | 79.17 ± 22.85 | 0.006* | ||
Control | 77.67 ± 15.54 | 47.75 ± 14.85 | 0.471 | ||
HDL-C (mg/dl) | ET | 41.25 ± 14.06 | 39.92 ± 10.93 | 0.785 | 0.239 |
RT | 35.08 ± 13.25 | 45.75 ± 12.77 | 0.020* | ||
Control | 36.00 ± 9.43 | 41.50 ± 7.22 | 0.040* |
Within-group P: paired t-test. Between-group P: one-way ANOVA, all others were presented as mean ± SD. sICAM-1: soluble intercellular adhesion molecule-1; IL-6: interleukin-6; hs-CRP: high-sensitivity C-reactive protein; TC: total cholesterol; TG: triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; ET: endurance training; RT: resistance training; SD: standard deviation
p < 0.05 significant difference compared to pretest
p < 0.05 significant difference between the three groups